Fluvoxamine is a potent inhibitor of cytochrome P4501A2

Biochemical Pharmacology

Volumn 45, Issue 6, 1993, Pages 1211-1214

  Brøsen, Kim ^a   Skjelbo, Erik ^a   Rasmussen, Birgitte B ^a   Poulsen, Henrik E ^b   Loft, Steffen ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CYTOCHROME P450 ISOENZYME; DRUG METABOLITE; FLUOXETINE; FLUVOXAMINE; LITOXETINE; NORCITALOPRAM; NORFLUOXETINE; PARACETAMOL; PAROXETINE; PHENACETIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; CONTROLLED STUDY; DONOR; DRUG CONCENTRATION; DRUG METABOLISM; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; LIVER MICROSOME; PRIORITY JOURNAL;

CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; FLUVOXAMINE; HUMAN; IMIPRAMINE; KINETICS; MICROSOMES, LIVER; OXIDOREDUCTASES, N-DEMETHYLATING; PHENACETIN; SUPPORT, NON-U.S. GOV'T; THEOPHYLLINE;

EID: 0027406654     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(93)90272-X     Document Type: Article

References (24)

1. Fluvoxamine—a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness
2. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature
3. Inhibitors of imipramine metabolism by human liver microsomes
4. The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine
5. A form of cytochrome P450 in man orthologous to form d in the rat catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking
6. Pharmacodynamics of imipramine and clinical outcome in depressed patients
7. Biotransformation of caffeine, paraxanthine, theophylline and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes
8. Possible interaction entre theophylline et fluvoxamine
9. Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy
10. Interaction between fluvoxamine and theophylline
11. Human cytochrome P-450pa (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines
12. Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation
13. Protein measurement with the Folin phenol reagent
14. Characterization of metronidazole metabolism by human liver microsomes
15. Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions
16. Purification and characterization of human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism
17. Phenacetin 0-deethylation by human liver microsomes: kinetics and propranolol inhibition
18. Uroporphyrinogen oxidation catalysed by reconstituted cytochrome P450IA2
19. Interaction between fluvoxamine and imipramine/desipramine in four patients
20. Furaphylline is a potent selective inhibitor of cytochrome P450IA2 in man
21. Accumulation of caffeine in healthy volunteers treated with furaphylline
22. Fluvoxamine-tricyclic antidepressant interaction